Alexander Gutmans

ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Roquette Frères SA manufactures and produces plant based-ingredients such as protein, fiber, polyols, starches, cereal sugars, cyclodextrins, and organic acids. It serves to pharmaceutical, cosmetics, food, nutrition, animal nutrition, and industrial sectors. The company was founded by Dominique Roquette and Germain Roquette in 1933 and is headquartered in Lestrem, France.

Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK.

Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France.

Part of Etypharm, Prographarm is a specialty hospital that provides non-psychiatric medical services. The company is based in Chateauneuf-en-Thymerais, France. Prographarm was acquired by Etypharm on August 01, 1999.

SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany.

CorCell, Inc. provides umbilical stem cell preservation & cord blood-banking services to use stem cells as future treatments for a variety of diseases and illnesses. The company collects umbilical cord blood stem cells from hospitals in all 50 states and abroad. CorCell has parterships with Maxxim Medical, Kimmel Cancer Center and Independence Blue Cross. CorCell was founded in 1995 and is located in Philadelphia, PA.

Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA.

Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.

SIS-SCHWAGER Group develops, produces and distributes products for the treatment of vascular diseases. Its product portfolio includes especially small as well as especially pressure-resistant balloon catheters, which retain their form even when exposed to high pressures. The company was founded by Michael Schwager in 2005 and is headquartered in Winterthur, Switzerland.

Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany.

Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany.